Gurpreet Singh
Gurpreet Singh is currently the Vice President, Managing Director Integrated Safety at IQVIA. He is based in UK and has a total of 18 years' experience in Pharma Industry of which 16+ years have been in Global Drug Development.
During these years he has had the opportunity to work with some top Global companies like Cognizant, Tata Consultancy, Novartis and Parexel. At Novartis he was the Global Head of PV Operations managing all Global PV activities. At Parexel he was the Senior Director PV Operations responsible for managing PV projects of top Global Pharma and Biotech companies.
Gurpreet is a certified Six Sigma and Project Management Professional. He has keen interest in Digital Transformation and Organization Culture and has successfully led various projects during his tenure in the Pharma Industry. He is an avid runner and a speaker at various Pharma conferences.
Gurpreet Singh
Vice President, Managing Director Integrated Safety
IQVIA
Thursday 6 June
Pharmacovigilance – Current Trends, Challenges and Opportunities
- Global Drug Development
- Pharmacovigilance Trends
- Challenges & Opportunities - 4 Key elements
- Pharmacovigilance - Technologies
Gurpreet Singh
Vice President, Managing Director Integrated Safety
IQVIA
Thursday 6 June
Panel Discussion: Navigating the Complexities of Drug Safety And the Digital Age
- Discuss the role of real-world data in pharmacovigilance and its impact on drug safety assessments
- Explore opportunities for leveraging digital health data for proactive adverse event monitoring and patient-reported outcomes
- Outsourcing landscape – Partnership model working – Technology and services
- Examine ethical dilemmas related to pharmacovigilance, including issues of patient privacy, informed consent, and the balance between public health surveillance and individual rights
- Examine how AI and ML technologies are transforming pharmacovigilance processes, including adverse event detection, signal detection, and risk assessment
